scholarly journals Cost and Threshold Analysis of the FinishIt Campaign to Prevent Youth Smoking in the United States

2018 ◽  
Vol 15 (8) ◽  
pp. 1662 ◽  
Author(s):  
Brian Weir ◽  
Jennifer Cantrell ◽  
David Holtgrave ◽  
Marisa Greenberg ◽  
Ryan Kennedy ◽  
...  
Keyword(s):  
Young Adults ◽  
Medical Care ◽  
Smoking Initiation ◽  
The United States ◽  
Base Case ◽  
Medical Care Costs ◽  
Life Years ◽  
Youth And Young Adults ◽  
The Impact ◽  
Care Costs

In 2014, Truth Initiative launched the national FinishIt campaign to prevent smoking initiation among youth and young adults. The significant changes in the communications landscape requires further analysis to determine resource requirements for public education campaigns relative to their impact. This analysis estimates the cost of the FinishIt campaign based on data from expenditure records and uses published estimates of the lifetime treatment costs and quality-adjusted life years associated with smoking. The total cost of the FinishIt campaign for 2014–2016 was $162 million. Under assumptions associated with the pessimistic base-case (no medical care costs saved through prevention), 917 smoking careers would need to be averted for the campaign to be cost-effective. Assuming smoking leads to increased medical care costs, 7186 smoking careers would need to be averted for the campaign to be cost-saving. Given these thresholds (917 and 7186) and the estimate of the impact of the previous truth campaign, the investments in the Truth Initiative’s FinishIt campaign are likely warranted for preventing smoking careers among youth and young adults.

scholarly journals Medical Care Costs Associated with Cancer Survivorship in the United States

2020 ◽  
Vol 29 (7) ◽  
pp. 1304-1312 ◽  
Author(s):  
Angela B. Mariotto ◽  
Lindsey Enewold ◽  
Jingxuan Zhao ◽  
Christopher A. Zeruto ◽  
K. Robin Yabroff
Keyword(s):  
United States ◽  
Medical Care ◽  
Cancer Survivorship ◽  
The United States ◽  
Medical Care Costs ◽  
Care Costs

scholarly journals The Impact of Obesity on Medical Care Costs and Labor Market Outcomes in the US

2018 ◽  
Vol 64 (1) ◽  
pp. 108-117 ◽  
Author(s):  
Adam Biener ◽  
John Cawley ◽  
Chad Meyerhoefer
Keyword(s):  
Medical Care ◽  
Healthcare Costs ◽  
Previous Literature ◽  
Medical Expenditures ◽  
Economic Outcomes ◽  
Medical Expenditure ◽  
Medical Care Costs ◽  
The Us ◽  
The Impact ◽  
Care Costs

Abstract BACKGROUND The prevalence of obesity has risen dramatically in most countries of the world, and the economic consequences of obesity are not well understood. METHODS We analyzed data from the Medical Expenditure Panel Survey (MEPS) for 2001–2015 and estimated the percentage of healthcare costs that were associated with adult obesity, both for the US as a whole and for the most populous states. We also reviewed the literature on the impact of obesity on economic outcomes such as medical care costs, employment, and wages. RESULTS The percent of US national medical expenditures devoted to treating obesity-related illness in adults rose from 6.13% in 2001 to 7.91% in 2015, an increase of 29%. Substantial differences existed across states; in 2015, some states (AZ, CA, FL, NY) devoted 5%–6% of medical expenditures to obesity, whereas others (NC, OH, WI) spent >12% of all healthcare dollars on obesity. A review of previous literature that exploited natural experiments to estimate causal effects found that obesity raises medical care costs and lowers wages and the probability of employment. CONCLUSIONS A substantial and rising percentage of healthcare costs are associated with obesity. This is true for the US, for individual states, for each category of expenditure, and for each type of payer. Previous literature generally found that obesity worsens economic outcomes, such as medical care costs, wages, and employment, and imposes negative external costs that may justify government intervention.

scholarly journals Economic value of insertable cardiac monitors in unexplained syncope in the United States

Open Heart ◽  
2021 ◽  
Vol 8 (1) ◽  
pp. e001263
Author(s):  
Brad S Sutton ◽  
Sarah L Bermingham ◽  
Alexander Diamantopoulos ◽  
Sarah C Rosemas ◽  
Stelios I Tsintzos ◽  
...  
Keyword(s):  
Diagnostic Testing ◽  
Economic Value ◽  
Cost Savings ◽  
The United States ◽  
Base Case ◽  
Payer Perspective ◽  
Life Years ◽  
Unexplained Syncope ◽  
The Cost ◽  
The Impact

IntroductionEarly use of insertable cardiac monitor (ICM) is recommended for patients with unexplained syncope following initial clinical workup, due to its superior ability to establish symptom-rhythm correlation compared with conventional testing (CONV). However, ICMs incur higher upfront costs, and the impact of additional diagnoses and resulting treatment on downstream costs and outcomes is unclear. We aimed to evaluate the cost-effectiveness of ICM compared with CONV for the diagnosis of arrhythmia in patients with unexplained syncope, from a US payer perspective.MethodsA Markov model was developed to estimate lifetime costs and benefits of arrhythmia diagnosis with ICM versus CONV, considering all related diagnostic and arrhythmia-related treatment costs and consequences. Cohort characteristics and costs were informed by original claims database analyses. Risks of mortality, syncopal recurrence, injury due to syncope and quality of life consequences from syncopal events were identified from the literature.ResultsICM was less costly and more effective than CONV. Most of the observed US$4532 cost savings were attributed to reduced downstream diagnostic testing. For every 1000 patients, ICM was projected to yield an additional 253 arrhythmia diagnoses and lead to treatment in an additional 168 patients. The ICM strategy resulted in overall improved outcomes (0.30 quality-adjusted life years gained), due to a reduction in syncope recurrence and injury resulting from arrhythmia treatment. The results were robust to changes in the base case parameters but sensitive to the model time horizon, underlying probability of syncope recurrence and prevalence of arrhythmias.ConclusionsOur model projected that early ICM for the diagnosis of unexplained syncope reduced long-term costs, and led to an improvement in overall clinical outcomes by shortening time to arrhythmia treatment. The cost of ICM was outweighed by savings arising from fewer downstream diagnostic episodes, and the increased cost of treatment was counterbalanced by fewer syncope-related event costs.

The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada

1992 ◽  
Vol 34 (9) ◽  
pp. 983-991 ◽  
Author(s):  
Steven Sheingold ◽  
David Churchill ◽  
Norman Muirhead ◽  
Andreas Laupacis ◽  
Roberta Labelle ◽  
...  
Keyword(s):  
Medical Care ◽  
Recombinant Human Erythropoietin ◽  
Hemodialysis Patients ◽  
Human Erythropoietin ◽  
Medical Care Costs ◽  
The Impact ◽  
Care Costs

scholarly journals The impact of smoking and quitting on household expenditure patterns and medical care costs in China

2009 ◽  
Vol 18 (2) ◽  
pp. 150-155 ◽  
Author(s):  
Y Xin ◽  
J Qian ◽  
L Xu ◽  
S Tang ◽  
J Gao ◽  
...  
Keyword(s):  
Medical Care ◽  
Household Expenditure ◽  
Expenditure Patterns ◽  
Medical Care Costs ◽  
The Impact ◽  
Care Costs
Sign in / Sign up

Export Citation Format

Share Document